Activation of the aryl hydrocarbon receptor pathway may ameliorate dextran sodium sulfate-induced colitis in mice

被引:78
作者
Takamura, Takeyuki
Harama, Daisuke
Matsuoka, Shuji [2 ]
Shimokawa, Naomi
Nakamura, Yuki
Okumura, Ko [3 ]
Ogawa, Hideoki [3 ]
Kitamura, Masanori [4 ]
Nakao, Atsuhito [1 ,3 ]
机构
[1] Univ Yamanashi, Dept Immunol, Fac Med, Chuo Ku, Yamanashi 4093898, Japan
[2] Juntendo Univ, Sch Med, Dept Pathol, Tokyo 113, Japan
[3] Juntendo Univ, Sch Med, Atopy Res Ctr, Tokyo 113, Japan
[4] Univ Yamanashi, Dept Mol Signaling, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi 4093898, Japan
关键词
aryl hydrocarbon receptor; colitis; mouse; prostaglandin; INFLAMMATORY-BOWEL-DISEASE; PROSTAGLANDINS; EPIDEMIOLOGY; INHIBITION;
D O I
10.1038/icb.2010.35
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The aryl hydrocarbon receptor (AhR) recognizes numerous small xenobiotic and natural molecules, such as dioxin and natural chemicals, and is involved in the metabolism of these compounds. AhR also has a regulatory role in inflammatory responses. This study investigated whether the activation of the AhR pathway affects dextran sodium sulfate (DSS)-induced colitis, an ulcerative colitis-like model, in mice. DSS-induced colitis was ameliorated by pretreatment with a potent AhR activator, 2,3,7, 8-tetrachlorodibenzo-p-dioxin (TCDD), in mice. In addition, the mice pretreated with TCDD showed increased prostaglandin E2 (PGE2) production in the colon, and inhibition of PGE2 production by indomethacin abrogated the inhibitory effects of TCDD on DSS-induced colitis. Collectively, the activation of the AhR pathway by TCDD may ameliorate DSS-induced colitis, at least in part, through PGE2 production. Immunology and Cell Biology (2010) 88, 685-689; doi:10.1038/icb.2010.35; published online 16 March 2010
引用
收藏
页码:685 / 689
页数:5
相关论文
共 26 条
[1]   The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein [J].
Barouki, Robert ;
Coumoul, Xavier ;
Fernandez-Salgueroc, Pedro M. .
FEBS LETTERS, 2007, 581 (19) :3608-3615
[2]   Inflammatory bowel disease and smoking -: A review of epidemiology, pathophysiology, and therapeutic implications [J].
Birrenbach, T ;
Böcker, U .
INFLAMMATORY BOWEL DISEASES, 2004, 10 (06) :848-859
[3]   TUMOR-NECROSIS-FACTOR INVOLVEMENT IN 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN-MEDIATED ENDOTOXIN HYPERSENSITIVITY IN C57BL/6J MICE CONGENIC AT THE AH LOCUS [J].
CLARK, GC ;
TAYLOR, MJ ;
TRITSCHER, AM ;
LUCIER, GW .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1991, 111 (03) :422-431
[4]   Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1 [J].
Cohn, SM ;
Schloemann, S ;
Tessner, T ;
Seibert, K ;
Stenson, WF .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (06) :1367-1379
[5]   DEXTRAN SULFATE SODIUM-INDUCED COLITIS OCCURS IN SEVERE COMBINED IMMUNODEFICIENT MICE [J].
DIELEMAN, LA ;
RIDWAN, BU ;
TENNYSON, GS ;
BEAGLEY, KW ;
BUCY, RP ;
ELSON, CO .
GASTROENTEROLOGY, 1994, 107 (06) :1643-1652
[6]   The aryl hydrocarbon receptor in immunity [J].
Esser, Charlotte ;
Rannug, Agneta ;
Stockinger, Brigitta .
TRENDS IN IMMUNOLOGY, 2009, 30 (09) :447-454
[7]   Loss of transforming growth factor β signalling in the intestine contributes to tissue injury in inflammatory bowel disease [J].
Hahm, KB ;
Im, YH ;
Parks, TW ;
Park, SH ;
Markowitz, S ;
Jung, HY ;
Green, J ;
Kim, SJ .
GUT, 2001, 49 (02) :190-198
[8]  
HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pa.35.040195.001515
[9]   The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut [J].
Kabashima, K ;
Saji, T ;
Murata, T ;
Nagamachi, M ;
Matsuoka, T ;
Segi, E ;
Tsuboi, K ;
Sugimoto, Y ;
Kobayashi, T ;
Miyachi, Y ;
Ichikawa, A ;
Narumiya, S .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (07) :883-893
[10]   Direct, continuous monitoring of air pollution by transgenic sensor mice responsive to halogenated and polycyclic aromatic hydrocarbons [J].
Kasai, Ayumi ;
Hiramatsu, Nobuhiko ;
Hayakawa, Kunihiro ;
Yao, Jian ;
Kitamura, Masanori .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2008, 116 (03) :349-354